Proxalutamide (GT0918) is an antagonist of the androgen receptor (AR) with oral activity. Proxalutamide (GT0918) can be used in prostate cancer and COVID-19 research.
Molecular Weight:
517.50
Purity:
>98%
CAS Number:
[1398046-21-3]
Formula:
C24H19F4N5O2S
Target:
Androgen Receptor
* VAT and and shipping costs not included. Errors and price changes excepted